<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Five Companies to Watch in Wound Diagnostics in 2023

By Kris Flinn on 4/25/23 9:30 AM

The need for effective wound diagnostics has never been greater. SmartTRAK highlights five companies that may advance the market in 2023

SmartTRAK forecasts the US Diagnostics Aids Market to more than double in size by 2026E. There is a significant need for diagnostic technologies in US wound care, with hard-to-heal wounds anticipated to exceed four million by 2026E and advanced wound care revenues growing at a five-year compound annual growth rate of over 6% according to the SmartTRAK US AWC Market Overview.

In this article, SmartTRAK focuses on five noteworthy companies and the key initiatives they have planned for 2023 and also reveals four organizations that could disrupt the market this year. The five are:

  • Spectral MD
    • It is now ten years since Spectral MD was first awarded US Biomedical Advanced Research and Development Authority (BARDA) funding to accelerate the commercialization of its DeepView technology, a portable imaging system that uses ...

  • MolecuLight
    • Since 2015, MolecuLight has been very visible and active with its MolecuLight i:X device, a handheld fluorescence imaging device that provides real-time visualization of bacteria in chronic wounds at ...

  • Podimetrics
    • Podimetrics is another company that has ridden the challenges of the early 2020s with great success. Revenues have doubled for three years running and Company infrastructure has been ...

  • Smith+Nephew
    • SNN has shown a greater desire to establish itself within wound diagnostics than any other major wound care player. In addition to the Company’s agreement with MolecuLight, in 2019, SNN also acquired ...

  • 3M
    • SmartTRAK estimates that 3M had a 19.5% share of the WW Advanced Wound Care Market in the first nine months of 2022, making them the number one player. Over 80% of the Company’s revenue is from ...

The US Diagnostic Aids Market is highly fragmented, with a variety of start-ups, academic institutions and established players attempting to commercialize a range of technologies. As well as the five companies already featured, SmartTRAK believes that the following organizations could disrupt the market in 2023 ...

Just click the button below to download and read the "Five Companies to Watch in Wound Diagnostics in 2023" Market Outlook article by Kris Flinn, SmartTRAK Senior Analyst, Wound. Download the Market Outlook Article


Topics: Wound Care
Continue Reading
2 min read

New Products, Strong Growth & Continuing Strength: Q422 Extremities Market Recap

By Lisa Mahan on 4/24/23 10:02 AM

Strong growth across market segments and new products coming to market signal continuing Extremities Market strength

SmartTRAK reports that the Q422 WW Extremities Market, WW Upper Extremities Market, WW Foot & Ankle Market, US Extremities Market, US Upper Extremities Market and the US Foot & Ankle Market were all up between +4.5% and +9.0% YoY.
 

Among the many topics covered in detail in SmartTRAK's comprehensive Q422 Extremities Market Recap* are:

  • Complete Q422 Extremities Market Overview and Highlights
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • New Shoulder Products Driving Growth with More Tech Updates Coming
  • Ankle Market Poised for Expansion with Next-Generation Implants and Technology
  • Renewed Manufacturer Focus along with New Product Intros Fuel Upper Extremities Fixation
  • Foot & Ankle Fixation Propelled by New Product Introductions
  • Q422 Regulatory Highlights
    • Fixation
    • Shoulder Replacement
    • Elbow Replacement
    • Ankle Replacement
    • Toe Replacement
Read the entire Q422 Extremities Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.Learn More about Subscribing to SmartTRAK
Continue Reading
2 min read

Sweet Smell of Roses: Q422 & FY22 US Orthobio Market Recap

By Freddy Buntoum on 4/20/23 11:35 AM

Total Orthobio market bouncing back and coming through 2022 smelling like a rose for the 2nd year in a row.

The US Orthobiologics (Orthobio) market performed well during Q4 and for FY22, and the sweet smell of roses seemed to celebrate a rebound to the market, with elective procedure recovery, new product launches, and pull-through from enabling technologies as drivers to growth and positive momentum. Q422 saw growth in all but one segment of the US Orthobio market, which somewhat offset a stronger finish of the quarter and of the year 2022. Nevertheless, Q422 and FY22 closed on high notes.
 

Among the many topics covered in detail in our comprehensive Q422/FY22 OrthoBio Recap* are:

  • Complete Q422 Trauma Market Overview and Highlights
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • US Bone Replacement
    • Good Momentum as Spine Rebounds and Products Launch
  • US Cartilage Replacement
    • Procedure Volumes Stabilizing
  • US Soft Tissue Replacement
    • Winter Months More Like a Sunny Day Rose Parade
  • US Meniscus Replacement 
    • Growth Dampened by a Non-Blooming Group of Small Players

In addition to the previously mentioned market growth drivers, and as SmartTRAK highlighted in its latest trends article, “What Lies Ahead for Orthobiologics in 2023 and Beyond”,* other contributing factors of growth in 2022 and indicators of future growth in the US Orthobio market, included a tremendous level of M&As, strategic alliances and investments in new technologies. Overall, the US Orthobio market performed above expectations and ...

Read the entire Q422 Orthobio Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Learn More about Subscribing to SmartTRAK

Continue Reading
4 min read

What's New and What's Next at Abbott Neuromodulation

By Anne Staylor on 4/18/23 9:30 AM

Rebecca Wilkins, DVP R&D Neuromodulation for Abbott, discusses the Eterna SCS, strategies for penetrating the market for PDN, the latest initiatives for DBS and DRG and what’s next for the Company in an interview with SmartTRAK.

Rebecca Wilkins, Divisional Vice President, Research and Development, Neuromodulation at Abbott, discusses Eterna, the Company’s newest rechargeable spinal cord stimulator, strategies for penetrating the market for painful diabetic neuropathy (PDN), the latest initiatives in deep brain stimulation and what’s next in terms of research and innovation an interview with SmartTRAK. 

To find out more, listen to the interview by clicking on the following video (19:41 min). A link to download a complete transcript of the interview is also provided below...just click Continue Reading.

Continue Reading
2 min read

New Products Propel Growth: Q422 Trauma Market Recap

By Natasha Weeks on 4/17/23 10:16 AM

New product introductions propelled growth for the Trauma segment during the fourth quarter.

Historically the top segments in the Trauma Market, Plates & Screws and IM Nails, didn’t disappoint in Q4 and fueled growth for the overall Trauma Market. During Q422, manufacturers specifically touted IM nailing and plating systems as revenue drivers. Top players emphasized the importance of offering robust plating and IM nailing portfolios to customers noting it was key for positioning strategies to compete in healthcare requests for proposals (RFPs) and tenders.
 

Among the many topics covered in detail in our comprehensive Q422 Trauma Market Recap* are:

  • Complete Q422 Trauma Market Overview and Highlights
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • Plates & Screws and IM Nails Propel Growth for the Quarter
  • Globus Continues to Make Strides in Trauma Filling Out Product Portfolio
  • Q422 Trauma Market Regulatory Highlights

The number one trauma player, DePuy Synthes* (46.6% Q4 US Trauma market share) attributed Q422 and full-year 2022 growth to market recovery along with market adoption of new introductions such as ...

Read the entire Q422 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More about Subscribing to SmartTRAK

Continue Reading
2 min read

Wound Care Today 2023: Low Growth Impacting the UK Advanced Dressings Market

By Kris Flinn on 4/11/23 9:30 AM

SmartTRAK reports on the Wound Care Today 2023 Conference, where a number of challenges facing UK Advanced Dressings companies were on display

The UK Advanced Dressings Market is projected to grow at a five-year compound annual growth rate (CAGR) of +1.9%, according to SmartTRAK estimates. The UK market is growing slower than any of the nine advanced dressings markets that SmartTRAK reports on, including the markets for Total Europe (+3.2%) and Worldwide (+5.0%). Given that the number of chronic wounds is increasing annually and the rate of UK inflation is in the double digits, why is the growth of the UK market so poor compared to other markets?

Among the may topics covered in detail in this comprehensive look into Wound Care 2023 article are:

  • Increasing Alignment of Advanced Dressing Portfolios
  • Increased Presence of Premium Priced Therapies
  • Digital Tools That Highlight Inappropriate Usage of Dressings
  • The Hidden Impact of Hidradenitis Suppurativa

Any usage of advanced dressings to manage HS is vulnerable to switching to products tailored to the condition. Quantifying the size of this market niche is challenging but could be an increasing area of focus in ...

To download and read the complete "Wound Care Today 2023: Low Growth Impacting the UK Advanced Dressings Market" perspective article by Kris Flinn, SmartTRAK's Senior Analyst, Wound, just click the button below.

Download the Article

Topics: Wound Care
Continue Reading
2 min read

Rough Waters: Q422 Arthroscopic Technologies Market Recap

By Andy Knapik on 4/10/23 10:40 AM

Rough Waters for the Arthroscopic Technologies Market in Q4

While some of the significant headwinds caused by COVID-19 are in the rearview mirror, the Arthroscopic Technologies Market was still hampered in the fourth quarter, with worldwide revenues up +2.8% over Q421.


Q422 saw a continued rise in procedure volumes globally which provided growth for the AT Disposables Market, which tends to trend with case volumes. On the capital side of the AT market, capital orders remained strong for items such as arthroscopic camera systems with new equipment purchases as well as an increasing need for replacement capital driving demand. However, supply chain and sterilization issues continue to hinder overall sales growth in both the consumable and capital sides of the Arthroscopic Technologies market.

Among the many topics covered in detail in our comprehensive Q422 Arthroscopic Technologies Market Recap* are:

Continue Reading
2 min read

The Future of Spine Enabling Tech for 2023

By Shelly Caruso on 4/4/23 9:33 AM

As the US Spine Enabling Technology Market shows signs of blossoming opportunity in 2023, SmartTRAK highlights three distinct trends continuing to gain traction in the coming year.

The US market for Spine Enabling Technology boasted modest YoY gains in nearly every quarter in 2022, showing signs of blossoming opportunity in 2023 as procedure volumes return to pre-pandemic levels. SmartTRAK projects the US Spine Enabling Technology Market will have a five-year CAGR of 25.1%, according to SmartTRAK Spine Enabling Tech Market Overview. Looking ahead, SmartTRAK sees three distinct trends continuing in 2023: the growing use of artificial intelligence (AI), the increasing use of “smart” innovations in robotics and the ongoing shift of spine cases to the ambulatory surgery center (ASC) setting.

Among the trends outlined and discussed in detail in this Market Outlook article are:

Trend #1: Growing Use of AI to Optimize Surgery and Predict Outcomes
It is no secret that AI is here to stay. In recent years, advances in deep learning and deep neural networks have fueled the introduction of a wave of AI and machine learning-based solutions across various medical applications. SmartTRAK reviews the development of AI in healthcare and the implementation of AI-driven imaging in orthopedics and ...

Trends #2: Increasing use of "Smart" Drilling and Haptic Feedback in Robotics. Current evidence remains unclear whether increased accuracy of implant placement associated with robotic assistance in spine surgery translates to improved patient outcomes. Nevertheless, robotic adoption is clearly increasing with market leader MDT highlighting “record-breaking quarters” in Mazor robotics for Q4FY22. SmartTRAK estimates the US Spine Robotics Market will reach ...

Trends #3: : Ongoing Shift of Non-complex Spine to ASCs. During the COVID-19 pandemic, hospital restrictions on non-urgent surgical cases prompted surgeons to take more cases to surgery centers. For a surgeon, ambulatory surgery centers (ASCs) can facilitate better economics, control and patient safety. In the pandemic aftermath, published research suggests there is a renewed focus on ...

To download and read the complete "The Future of Spine Enabling Tech for 2023" article by Shelly Caruso, SmartTRAK Market Analyst/Medical Writer, just click the button below. Download the Article

Continue Reading
2 min read

A Glimpse into 2023: Regen Med Trends

By Freddy Buntoum on 3/31/23 4:04 PM

PRP and Adipose Through the Looking Glass

The interest and demand for regenerative medicine for various conditions and injuries have increased exponentially over the last decade. From January 1, 1990 to December 31, 2012, google searches for regenerative medicine totaled 21,600,000. With increased publicity about stem cells and advancements in cell and gene therapies, biomaterials and tissue engineering, google searches increased nearly ten-fold to 212,000,000 from 1/1/13 to 2/27/23.

Is regenerative medicine really the way of the future? In this article, SmartTRAK looks at the macroeconomic environment going into 2023, as well as some of the latest trends, with a special focus on two segments: platelet-rich-plasma (PRP) and adipose tissue.
 
Among the may topics covered in detail in this comprehensive article are:
  • PRP Trends and the Impacts to 2023 and Beyond
    • Headwinds in 2023
    • Trends in PRP Clinical Trials
    • Anticipated 2023 US PRP Market Share Standings
  • Adipose Trends and the Impacts to 2023 and Beyond
    • Adipose tissue therapy gaining interest in the field of sports medicine
    • Patient demand for minimally-invasive solutions
    • Adipose-derived cell therapies for OA and Degenerative Disc Disease
So is regenerative medicine the way of the future? Time will tell, however, SmartTRAK feels that demand and interest by multiple stakeholders, along with recent trends, medical and legal advancements and investments is tipping the scale to ...

To download and read the complete "A Glimpse into 2023: Regen Med Trends" article by Freddy Buntoum, SmartTRAK's Senior Analyst, Orthobiologics and Regenerative Medicine, just click the button below.Download the Article

Continue Reading
2 min read

AAOS 2023: Total Joint Viewpoint

By Lisa Mahan on 3/27/23 11:00 AM

AAOS approaches “Next to Normal” as surgeons and industry focus on solutions to meet the needs of patients returning to joint replacement

If an ad agency had branded the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting this year, the tagline would have read “Getting back to normal.” Surgeons toured the exhibit hall throughout the day not just during dedicated hours. The meeting felt as if it had come back to life with industry symposiums and conference presentations often seeing standing-room-only crowds when a few years ago even the exhibit floor felt like a ghost town. And while some of the large orthopedic companies slightly scaled down their booth space, several mid-tier and small market players increased their presence at the meeting in an attempt to pique surgeon interest. So what was the buzz at AAOS 2023 related to hip and knee replacement? In this article, SmartTRAK outlines some of the key takeaways, including: 
  • Procedure Recovery May Signal Return of Deferred Procedures
    • Both clinicians and company representatives at the meeting revealed to SmartTRAK that they are seeing increased hip and knee procedure volumes heading into 2023. The overall consensus was ...

  • The Move to Outpatient Joint Replacement Continues.
    • Data presented at AAOS 2023 continues to support the move of joint replacement surgeries to an outpatient setting. A study focusing on patient satisfaction after outpatient joint replacement in an academic medical center reported ...

  • Cementless Knee Trend Growing Despite Mixed Results
    • Clinical evidence presented at AAOS showed mixed results for cementless total knees with some studies reporting excellent outcomes and others identifying increased risks associated with ...

  • Assistive Technologies Growing and Evolving
    • Assistive technology presentations and booth exhibits seemed to generate the most interest at AAOS 2023. Elise Wolf, SmartTRAK’s assistive technologies expert, noted the most innovative products and ...

To download and read the complete "AAOS 2023: Total Joint Viewpoint" article by SmartTRAK's Lisa Mahan,  VP Product Development & IT, Sr. Analyst TJ&E, just click the button below. Download the AAOS 2023 Article

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles